Sanofi: Number of Employees 2006-2019 | SNY

Interactive chart of Sanofi (SNY) annual worldwide employee count from 2006 to 2019.
  • Sanofi total number of employees in 2018 was 104,226, a 2.2% decline from 2017.
  • Sanofi total number of employees in 2017 was 106,566, a 0.27% decline from 2016.
  • Sanofi total number of employees in 2016 was 106,859, a 7.59% decline from 2015.
  • Sanofi total number of employees in 2015 was 115,631, a 1.88% increase from 2014.
Sanofi Annual Number of Employees
2018 104,226
2017 106,566
2016 106,859
2015 115,631
2014 113,496
2013 112,128
2012 111,974
2011 113,719
2010 101,575
2009 104,867
2008
2007
2006
2005
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $127.085B $40.002B
Sanofi-Aventis is a global pharmaceutical company that contributes to enhance life by providing medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company is engaged in the research, development, manufacture and marketing of healthcare products. Its strategy is built around three priorities to reach its goals and ensure sustainable growth. The priorities are: increasing innovation in Research and Development, adapting Group structures to future challenges and seizing external growth opportunities. Sanofi-Aventis specializes in six therapeutic areas: thrombosis, cardiovascular, metabolic disorders, oncology, central nervous system (CNS) and internal medicine. The Company offers vaccines in five areas: pediatric combination vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines. Sanofi-Aventis is headquartered in Paris, France.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.914B 17.09
Roche Holding AG (RHHBY) Switzerland $300.375B 0.00
Novartis AG (NVS) Switzerland $220.677B 18.38
Merck (MRK) United States $210.018B 15.89
Pfizer (PFE) United States $198.398B 12.15
Novo Nordisk (NVO) Denmark $150.392B 25.82
AbbVie (ABBV) United States $139.349B 10.54
Eli Lilly (LLY) United States $135.806B 23.51
AstraZeneca (AZN) United Kingdom $128.407B 27.65
GlaxoSmithKline (GSK) United Kingdom $106.698B 13.53
Bristol-Myers Squibb (BMY) United States $106.180B 13.95
Bayer (BAYRY) Germany $75.462B 11.18
H Lundbeck (HLUYY) Denmark $7.744B 13.45